Zacks Research Has Bullish Outlook for McKesson Q4 Earnings

McKesson Co. (NYSE:MCK - Free Report) - Research analysts at Zacks Research lifted their Q4 2025 EPS estimates for shares of McKesson in a report released on Thursday, April 3rd. Zacks Research analyst R. Department now expects that the company will post earnings of $9.71 per share for the quarter, up from their prior forecast of $9.70. The consensus estimate for McKesson's current full-year earnings is $32.77 per share. Zacks Research also issued estimates for McKesson's Q4 2025 earnings at $9.71 EPS, Q2 2026 earnings at $8.50 EPS, Q2 2026 earnings at $8.50 EPS, Q4 2026 earnings at $9.53 EPS, Q4 2026 earnings at $9.53 EPS and Q4 2027 earnings at $12.05 EPS.

Other research analysts have also recently issued reports about the stock. Wells Fargo & Company boosted their target price on shares of McKesson from $641.00 to $691.00 and gave the company an "equal weight" rating in a research note on Friday, March 14th. Mizuho increased their price objective on McKesson from $630.00 to $690.00 and gave the company a "neutral" rating in a report on Thursday, April 3rd. Bank of America lowered their target price on McKesson from $680.00 to $650.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. StockNews.com lowered McKesson from a "strong-buy" rating to a "buy" rating in a report on Friday, February 14th. Finally, Citigroup lowered their target price on shares of McKesson from $713.00 to $677.00 and set a "buy" rating on the stock in a report on Friday, January 10th. Three investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $661.00.

Remove Ads

McKesson Price Performance

Shares of NYSE MCK traded up $24.07 during mid-day trading on Friday, reaching $676.90. 788,795 shares of the company's stock were exchanged, compared to its average volume of 869,762. The firm has a market capitalization of $84.83 billion, a price-to-earnings ratio of 30.96, a price-to-earnings-growth ratio of 1.29 and a beta of 0.49. The firm has a 50-day moving average price of $636.50 and a two-hundred day moving average price of $588.48. McKesson has a 52 week low of $464.42 and a 52 week high of $728.32.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of MCK. Capital A Wealth Management LLC bought a new position in shares of McKesson in the fourth quarter worth approximately $26,000. Millstone Evans Group LLC purchased a new position in shares of McKesson in the fourth quarter valued at about $28,000. Synergy Asset Management LLC bought a new position in shares of McKesson during the fourth quarter valued at about $32,000. Crews Bank & Trust purchased a new stake in shares of McKesson during the fourth quarter worth about $33,000. Finally, Atala Financial Inc bought a new stake in shares of McKesson in the fourth quarter worth about $34,000. Hedge funds and other institutional investors own 85.07% of the company's stock.

Insider Buying and Selling at McKesson

In other news, CEO Brian S. Tyler sold 8,961 shares of the business's stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $597.99, for a total value of $5,358,588.39. Following the completion of the sale, the chief executive officer now directly owns 60,664 shares in the company, valued at approximately $36,276,465.36. The trade was a 12.87 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Leann B. Smith sold 188 shares of McKesson stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total transaction of $114,602.92. Following the completion of the transaction, the executive vice president now owns 1,051 shares in the company, valued at approximately $640,679.09. The trade was a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 18,110 shares of company stock worth $10,855,706 over the last 90 days. Corporate insiders own 0.11% of the company's stock.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 3rd were paid a $0.71 dividend. The ex-dividend date of this dividend was Monday, March 3rd. This represents a $2.84 dividend on an annualized basis and a yield of 0.42%. McKesson's dividend payout ratio is presently 13.00%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.